(123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations

Reduced uptake of (123)I- metaiodobenzylguanidine (MIBG) on cardiac gammagraphy and impaired odor identification are markers of neurodegenerative diseases with Lewy bodies (LB) as a pathological hallmark, such as idiopathic Parkinson’s disease (IPD). LRRK2 patients present with a clinical syndrome i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Valldeoriola, Francesc, Gaig, Carles, Muxí, Africa, Navales, Ignacio, Paredes, Pilar, Lomeña, Francisco, De la Cerda, Andres, Buongiorno, Mariateresa, Ezquerra, Mario, Santacruz, Pilar, Martí, Maria Jose, Tolosa, Eduardo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer-Verlag 2011
Pynciau:
Original Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101340/
https://ncbi.nlm.nih.gov/pubmed/21221623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-010-5896-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg